Learning Zone
IFN-Gamma in Hyperinflammation: Key Insights
Hemophagocytic lymphohistiocytosis / macrophage activation syndrome (HLH/MAS) is a rare and severe disease associated with high mortality rates. This Learning Zone will provide resources to help you recall key features of secondary HLH/MAS, overcome diagnostic challenges, and select the right treatment for your patients.
Check in here over the next 12 months to:
- Recall the clinical features of this rare disease as well as the impact of delayed diagnosis on patient outcomes
- Review guideline recommendations and hear expert advice on the early diagnosis of secondary HLH/MAS and how to select the right treatment approach
- Find out more about the role of biomarkers in disease management, from diagnosis to disease monitoring
- View case study examples of differential diagnosis, to help you navigate complex treatment selection and apply the latest guidance to your clinical practice
Developed independently by EPG Health, which received an educational grant from Sobi, awarded to EPG Health to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.
Updates in your area
of interest
of interest
Articles your peers
are looking at
are looking at
Bookmarks
saved
saved
Days to your
next event
next event